Mycophenolate Sodium

้บฆ่€ƒ้…š้’ 

Report date: 2024/06/03 11:21:00
NME

Base Information

Drug NameMycophenolate Sodium
Drug Alias NameMycophenolic Sodium้œ‰้…š้…ธ้’ ้บฆ่€ƒ้…š้…ธ้’ ้บฆ่€ƒ้…ธ้’ ็ฑณ่Š™ +[11]ย 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInosine-5'-monophosphate dehydrogenase (IMPDH) inhibitors
TargetsInosine-5'-monophosphate dehydrogenase (IMPDH)
Therapy Area/IndicationsRejection of pancreatic transplantationRejection of renal transplantationAutoimmune Diseases +[7]ย 
Global Approved IndicationsRejection of renal transplantation
Approved Indications in ChinaRejection of renal transplantation
Original Approved Country/TerritorySwitzerland
Original Approved Date2002/10/01
Country/TerritoryCanadaUnited StatesGermany +[5]ย 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma Schweiz AgNovartis Pharma AgNovartis Pharmaceuticals Corp
Inactive CompaniesResearch Institute Of The Mcgill University Health CentreUniversity Of FloridaMcgill University Health Centre
Active IndicationsRejection of renal transplantation
Inactive IndicationsRejection of pancreatic transplantationAutoimmune DiseasesKidney Failure, Chronic +[6]ย 

Other Information

ATC CodeL04AA06
Related LinksWikipediaDrugBankKEGG